Sign in

CIK 0001515673 · Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
272546083
Phone
415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Acquisition or sale completed · Results of operations · Exit or restructuring costs
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. 4 Insider Changes in Ownership
  7. 8-K Event Other events
  8. 8-K Event Material agreement
  9. 8-K Event Material agreement
  10. 8-K Event Other events
  11. 4 Insider Changes in Ownership
  12. 144 Insider Sale of Securities
  13. 4 Insider Changes in Ownership
  14. 8-K Event Other events
  15. 8-K Event Other events
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 8-K Event Other events
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 10-Q Report Quarterly Report

Page 1 of 58 · 1,149 filings